Atlas Trials

Tadalafil for Severe Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease

Clinical trial NCT05844462 · RECRUITING

Trial details

NCT number
NCT05844462
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Pulmonary HypertensionChronic Obstructive Pulmonary Disease
Start date
2024-02-01
Primary completion
2027-10-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.